Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Evaluation Of Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes Of One Hundred Thirty-Two Patients With Myelodysplastic Syndrome (MDS) Or Chronic Myelomonocytic Leukemia (CMML) Up To Age Seventy-Five and The Effect Of Pre-Transplant 5-Azacitidine

Teresa Field, MD, PhD, Janelle Perkins, PharmD, Marcie Tomblyn, MD, MS, Ryan Hillgruber, Taiga Nishihori, MD, Asmita Mishra, MD, Joseph Pidala, MD, MS, Ernesto Ayala, MD, Frederick L Locke, MD, Melissa Alsina, MD, Brian C. Betts, MD, Eric Padron, MD, Hugo F Fernandez, MD, Jeffrey E Lancet, MD, Alan List, MD, Rami S Komrokji, MD, Mohamed A. Kharfan-Dabaja, MD, Claudio Anasetti, MD

Blood (2013) 122 (21): 2152.

https://doi.org/10.1182/blood.V122.21.2152.2152

Published: 2013

Journal Articles

Th17 Lymphocytes In Human Gvhd Target Tissues Are Associated With Disease Severity and Refractoriness To Systemic Glucocorticoid Therapy

Joseph Pidala, MD, MS, Elizabeth M. Sagatys, MD, Mark Lloyd, MS, Jongphil Kim, PhD, Binglin Yue, MS, Brian C Betts, MD, Claudio Anasetti, MD

Blood (2013) 122 (21): 2054.

https://doi.org/10.1182/blood.V122.21.2054.2054

Published: 2013

Journal Articles

Influence Of Organ Scores On Mortality In Chronic GVHD: Results From The Chronic GVHD Consortium

Yoshihiro Inamoto, MD, PhD, Barry E. Storer, PhD, Daniel J. Weisdorf, MD, Georgia B. Vogelsang, MD, Joseph Pidala, MD, MS, Xiaoyu Chai, MS, Mary E. D. Flowers, MD, Mukta Arora, MD, MS, Sally Arai, MD, Jeanne Palmer, MD, Corey S. Cutler, MD, Madan Jagasia, MBBS, MS, Steven Z. Pavletic, MD, Stephanie J. Lee, MD, MPH, Paul J. Martin, MD

Blood (2013) 122 (21): 4614.

https://doi.org/10.1182/blood.V122.21.4614.4614

Published: 2013

Journal Articles

A Phase I/II Trial Evaluating The Use Of a Histone Deacetylase Inhibitor Panobinostat (LBH589) In Addition To Glucocorticoids In Patients With Acute Graft-Versus-Host Disease

Lia Perez, MD, Hugo F Fernandez, MD, Marcie Tomblyn, MD, MS, Frederick L Locke, MD, Teresa Field, MD, PhD, Joseph Pidala, MD, MS, Erika Elmer, CCRP, Francisca Beato, BS, Alejandro Villagra, PhD, Claudio Anasetti, MD

Blood (2013) 122 (21): 3308.

https://doi.org/10.1182/blood.V122.21.3308.3308

Published: 2013

Journal Articles

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: A Cibmtr Analysis

John Koreth, MBBS, DPhil, Kwang Woo Ahn, PhD, Joseph Pidala, MD, MS, James L. Gajewski, MD, Hailin Wang, MS, Marcelo A. Fernandez Viña, PhD, D(ABHI), Stephen Spellman, MBS, Stephanie J. Lee, MD, MPH

Blood (2013) 122 (21): 547.

https://doi.org/10.1182/blood.V122.21.547.547

Published: 2013

Journal Articles

Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients?

Areej El-Jawahri, MD, Joseph Pidala, MD, MS, Xiaoyu Chai, MS, William A. Wood, MD, MPH, Nandita Khera, MD, MPH, Mukta Arora, MD, MS, Samantha M. Jaglowski, MD, MPH, Stephanie J. Lee, MD, MPH, Yi-Bin Chen, MD

Blood (2013) 122 (21): 725.

https://doi.org/10.1182/blood.V122.21.725.725

Published: 2013

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Recommended Tools for Joint Chronic Graft-Versus-Host Disease: Results From the Chronic Gvhd Consortium

Yoshihiro Inamoto, MD, PhD, Xiaoyu Chai, MS, Brenda Kurland, PhD, Daniel J. Weisdorf, MD, Paul J. Martin, MD, David Jacobsohn, MD, Joseph Pidala, MD, MS, Jeanne Palmer, MD, Sally Arai, MD, Corey Cutler, MD, MPH, FRCPC, Madan Jagasia, MBBS, MS, Mary E.D. Flowers, MD, Mukta Arora, MD, Steven Z. Pavletic, MD, Georgia B. Vogelsang, MD, Stephanie J. Lee, MD, MPH, Paul A. Carpenter, MD

Blood (2012) 120 (21): 464.

https://doi.org/10.1182/blood.V120.21.464.464

Published: 2012

Journal Articles

Tregs Specific for Minor Histocompatibility Antigens

Anandharaman Veerapathran, PhD, Joseph Pidala, MD, MS, Francisca Beato, BS, William E. Janssen, PhD, Xue-Zhong Yu, M.D., M.S., Claudio Anasetti, MD

Blood (2012) 120 (21): 1891.

https://doi.org/10.1182/blood.V120.21.1891.1891

Published: 2012

Journal Articles

Gastrointestinal and Hepatic Involvement in Chronic Gvhd: An Analysis From the Chronic Gvhd Consortium

Joseph Pidala, MD, MS, Xiaoyu Chai, MS, Brenda Kurland, PhD, Mukta Arora, MD, Corey Cutler, MD, MPH, FRCPC, Mary E.D. Flowers, MD, Yoshi Inamoto, MD, Madan Jagasia, MBBS, MS, Nandita Khera, MD, Jeanne Palmer, MD, Georgia Vogelsang, Stephanie J Lee, MD, MPH

Blood (2012) 120 (21): 1940.

https://doi.org/10.1182/blood.V120.21.1940.1940

Published: 2012

Journal Articles

The Anti-CD25 Antibody Daclizumab Delays Treg Reconstitution, Promotes CD4 Memory, and Does Not Prevent Acute or Chronic Gvhd After Allogeneic Stem Cell Transplantation

Frederick L Locke, MD, Joseph Pidala, MD, MS, Barry Storer, PhD, Paul J. Martin, MD, Michael A Pulsipher, MD, Thomas Chauncey, MD, PhD, Niels Jacobsen, MD, DMSC, Nikolaus Kroeger, MD, Irwin Walker, MBBS, Mary C Territo, Susan Light, MD, Ginna G Laport, MD, Auayporn Nademanee, MD, Raymond Powles, MD, Armand Keating, MD, Gerard Socie, MD, Claudio Anasetti, MD

Blood (2012) 120 (21): 4195.

https://doi.org/10.1182/blood.V120.21.4195.4195

Published: 2012

Journal Articles

Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies

Mohamed A. Kharfan-Dabaja, MD, Rahul Mhaskar, MPH, PhD, Tea Reljic, Joseph Pidala, MD, MS, Janelle Perkins, PharmD, Benjamin Djulbegovic, MD, PhD, Ambuj Kumar, MD, MPH

Blood (2012) 120 (21): 4168.

https://doi.org/10.1182/blood.V120.21.4168.4168

Published: 2012

Journal Articles

Purification and Expansion of Antigen-Specific Human Tregs for Clinical Application Using a Single Step CD25 Positive Selection

Francisca Beato, BS, Anandharaman Veerapathran, PhD, Joseph Pidala, MD, MS, William E. Janssen, PhD, Claudio Anasetti, MD

Blood (2012) 120 (21): 1899.

https://doi.org/10.1182/blood.V120.21.1899.1899

Published: 2012

Journal Articles

Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium

Yoshihiro Inamoto, MD, Corey S. Cutler, MD, MPH, FRCPC, Xiaoyu Chai, MS, Mukta Arora, MD, Paul J. Martin, MD, Joseph Pidala, MD, MS, Jeanne Palmer, MD, Steven Z. Pavletic, MD, Madan H. Jagasia, MD, David Jacobsohn, MD, Paul A. Carpenter, MD, Mary E.D. Flowers, MD, Nandita Khera, MD, Georgia B. Vogelsang, MD, Daniel J. Weisdorf, MD, Barry Storer, PhD, Stephanie J. Lee, MD, MPH

Blood (2011) 118 (21): 1988.

https://doi.org/10.1182/blood.V118.21.1988.1988

Published: 2011

Journal Articles

Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T Cells (Treg) After Allogeneic Hematopoietic Cell Transplantation (HCT), and Is More Effective Than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft Vs. Host Disease (GVHD) and Moderate to Severe Chronic Gvhd

Joseph Pidala, MD, MS, Jongphil Kim, PhD, Heather Jim, PhD, Hugo F. Fernandez, MD, Marcie Tomblyn, MD, MS, Mohamed A Kharfan-Dabaja, MD, Brian C. Betts, MD, Taiga Nishihori, MD, Mian Xu, William E. Janssen, PhD, Frederick L Locke, MD, Ernesto Ayala, MD, Lia Perez, MD, Janelle Perkins, PharmD, Teresa Field, MD, PhD, Leonel Ochoa, Melissa Alsina, MD, Claudio Anasetti, MD

Blood (2011) 118 (21): 323.

https://doi.org/10.1182/blood.V118.21.323.323

Published: 2011

Journal Articles

Fludarabine and Targeted Busulfan Is Safe and Effective Conditioning Before Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in First Remission

Ghada M Kunter, MD, Janelle Perkins, PharmD, Lia Perez, MD, Joseph Pidala, MD, MS, Teresa Field, MD, PhD, Marcie Tomblyn, MD, MS, Hugo F. Fernandez, MD, Claudio Anasetti, MD

Blood (2011) 118 (21): 891.

https://doi.org/10.1182/blood.V118.21.891.891

Published: 2011

Journal Articles

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Blood (2011) 118 (21): 115.

https://doi.org/10.1182/blood.V118.21.115.115

Published: 2011

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

A Phase 2 Study of Bortezomib Plus High-Dose Melphalan (Mel/Vel) Conditioning for Autologous Hematopoietic Cell Transplantation In Multiple Myeloma,

Taiga Nishihori, MD, Leonel Ochoa, Joseph Pidala, MD, MS, Kenneth H. Shain, MD, PhD, Rachid Baz, MD, Christine Simonelli, RN, Dan Sullivan, Claudio Anasetti, MD, Melissa Alsina, MD

Blood (2011) 118 (21): 4158.

https://doi.org/10.1182/blood.V118.21.4158.4158

Published: 2011

Journal Articles

Comparison of Proposed NIH Response Criteria with Clinician-Reported Changes in Organ-Specific and Overall Response

Jeanne Palmer, MD, Stephanie J. Lee, MD, MPH, Xiaoyu Chai, MS, Barry Storer, PhD, Joseph Pidala, MD, MS, Corey S. Cutler, MD, MPH, FRCPC, Mukta Arora, MD, Mary E.D. Flowers, MD, Steven Z. Pavletic, MD, Georgia B. Vogelsang, MD, Yoshihiro Inamoto, MD, Madan Jagasia, MD, MS, Chen George, MD, Paul J. Martin, MD

Blood (2011) 118 (21): 1978.

https://doi.org/10.1182/blood.V118.21.1978.1978

Published: 2011

NARROW

Evaluation Of Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes Of One Hundred Thirty-Two Patients With Myelodysplastic Syndrome (MDS) Or Chronic Myelomonocytic Leukemia (CMML) Up To Age Seventy-Five and The Effect Of Pre-Transplant 5-Azacitidine

Th17 Lymphocytes In Human Gvhd Target Tissues Are Associated With Disease Severity and Refractoriness To Systemic Glucocorticoid Therapy

Influence Of Organ Scores On Mortality In Chronic GVHD: Results From The Chronic GVHD Consortium

A Phase I/II Trial Evaluating The Use Of a Histone Deacetylase Inhibitor Panobinostat (LBH589) In Addition To Glucocorticoids In Patients With Acute Graft-Versus-Host Disease

HLA-Mismatch Is Associated With Worse Outcomes After Unrelated Donor Reduced Intensity Conditioning Hematopoietic Cell Transplantation: A Cibmtr Analysis

Do Older Patients With Moderate-Severe Chronic Graft-Versus-Host Disease Differ From Younger Patients?

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Recommended Tools for Joint Chronic Graft-Versus-Host Disease: Results From the Chronic Gvhd Consortium

Tregs Specific for Minor Histocompatibility Antigens

Gastrointestinal and Hepatic Involvement in Chronic Gvhd: An Analysis From the Chronic Gvhd Consortium

The Anti-CD25 Antibody Daclizumab Delays Treg Reconstitution, Promotes CD4 Memory, and Does Not Prevent Acute or Chronic Gvhd After Allogeneic Stem Cell Transplantation

Mycophenolate Mofetil versus Methotrexate for Prevention of Acute Graft-Versus-Host Disease: Results of a Systematic Review Limited to Prosepective Randomized Controlled Studies

Purification and Expansion of Antigen-Specific Human Tregs for Clinical Application Using a Single Step CD25 Positive Selection

Calculated NIH Response Correlates with Changes in Patient-Reported Symptoms but Not with Quality of Life: Results From the Chronic Gvhd Consortium

Sirolimus/Tacrolimus Facilitates Preferential Recovery of Regulatory T Cells (Treg) After Allogeneic Hematopoietic Cell Transplantation (HCT), and Is More Effective Than Methotrexate/Tacrolimus in Preventing Grade II-IV Acute Graft Vs. Host Disease (GVHD) and Moderate to Severe Chronic Gvhd

Fludarabine and Targeted Busulfan Is Safe and Effective Conditioning Before Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia in First Remission

A Decision Analysis of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients with De-Novo Myelodysplastic Syndrome (MDS): Early Transplantation Offers Survival Benefit in Higher-Risk MDS

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

A Phase 2 Study of Bortezomib Plus High-Dose Melphalan (Mel/Vel) Conditioning for Autologous Hematopoietic Cell Transplantation In Multiple Myeloma,

Comparison of Proposed NIH Response Criteria with Clinician-Reported Changes in Organ-Specific and Overall Response

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only